
|Articles|July 15, 2006
Prophylactic, therapeutic use of mitomycin-C considered safe
Literature review shows single application of low-dose MMC can prevent, treat haze after surface procedures
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
Opus Genetics launches phase 1/2 MERTK gene therapy trial
3
Eye exams could enable earlier detection of systemic disease
4
FDA approves NDA labeling supplement allowing re-administration of iDose TR
5



























